Apoptosis is co-ordinated by a family of cysteine proteases, the caspases, that dismantle the cell by targeting a panoply of proteins for limited proteolysis. T h e mammalian caspase family contains 14 members, a subset of which participates in apoptosis, with the remainder likely to be involved in the processing of pro-inflammatory cytokines. Apical caspase activation events are typically initiated by adaptor molecules that promote cas-
Introduction
Cells routinely die as a natural part of the life cycle of multicellular organisms and are replaced through ongoing cell division. It is now well D N A Damage Signalling and Apoptosis established that cell division and cell death complement one another and that both are under complex molecular control. Cells can die because they are injured, infected, malfunctional, or simply because they are no longer required. In most of these cases, apoptosis is used as a means of safely eliminating cells that may otherwise accumulate to cause disease. Studies conducted over the past 7-10 years have revealed a complex web of molecules (the death machinery) that function to dismantle cells from within under appropriate circumstances. T h e death machinery can be activated by diverse stimuli and has as its central component a group of proteolytic enzymes called caspases that act as controlled demolition experts. Upon activation, the co-operative actions of the caspases produce alterations in the cell (compaction of chromatin, plasma membrane blebbing, separation of the cell into intact vesicles) that we recognize as the ' apoptotic phenotype '. Here, we discuss the caspases, how they become activated during apoptosis, some of the controls placed upon them and, finally, their cellular substrates.
Caspases enter the picture
Caspases were first implicated as components of the cell death machinery by studies conducted on the simple nematode worm Caenorhabditis elegans. Through genetic analysis of cell-death defective (CED) worm mutants, it was found that the product of the ced-3 gene was required for all developmental-related programmed cell deaths in the worm. In a landmark paper by Yuan et al. in 1993 [l] , it was reported that CED-3 was closely related to a novel human protease that had just been cloned from macrophages, interleukin-lp converting enzyme (ICE). Although ICE was subsequently found not to play a central role in apoptosis, the initial report of the homology between CED-3 and ICE was rapidly followed by the discovery of a slew of related 'ICE-like' proteases. These ICE-like proteases, which were subsequently renamed 'caspases ', are now known to occupy a central position at the heart of the cell death machinery. Fourteen mammalian caspases have now been identified, with caspase-11 and caspase-12 identified only in the mouse to date Caspases (cysteine aspartate-specific proteases) exhibit primary specificity for aspartic acid residues, a very uncommon substrate site preference [3, 4] . These enzymes exist in most, if not all, cells as relatively inactive precursors (procaspases) that are converted into their active forms by [ 2-51. proteolytic cleavage at internal aspartic acid residues, which separates the caspase into separate small and large subunits. This suggests that caspases either become activated by autoproteolysis or by other caspases activated upstream. In fact, both scenarios are correct with some caspases capable of autoproteolytic activation upon aggregation facilitated by adaptor proteins, while others seem to require direct processing by other caspases. Caspases can be broadly divided into two functional sub-groups : those that are activated during apoptosis (caspase-2, -3,-6, -7, -8, -9 and -10) and those that have been implicated in the processing of pro-inflammatory cytokines during the immune response (caspase-1, -4, -5 and -11). However, it should be stressed that the boundaries between these sub-groups are not sharply drawn as we still know surprisingly little about the role of several of the caspases (e.g. caspase-2, -4, -5, -7, -12 and -13) in apoptosis or inflammation.
Initiator and effector caspases
Caspases that have been implicated in apoptosis have been divided into two further sub-groups based on their actual or predicted positions in the apoptosis-associated caspase cascade. Upstream or initiator caspases (caspase-2, -8, -9 and -10) are generally thought to be responsible for initiating caspase activation cascades during apoptosis. Apical caspases tend to have long N-terminal prodomains with protein-protein interaction motifs [caspase recruitment domains (CARDS) or death effector domains] that are also present in caspase adaptor molecules such as FADD, RAIDD and Apaf-1 (apoptotic protease activating factor-1), which serve to promote caspase aggregation and activation at the onset of apoptosis [4-81. T h e second group, the downstream, or effector, caspases (caspase-3, -6 and -7) that are thought to be responsible for the actual demolition of the cell during apoptosis, tend to have short or absent pro-domains. T h e key to understanding apoptosis lies with understanding the mechanisms of caspase activation, their substrates, and the cellular controls that regulate caspase activity.
Setting the caspase cascade in motion
T h e first evidence for caspase aggregation as a mechanism of caspase activation came from observations that caspase-8 was recruited to the plasma membrane-associated Fas 'death receptor' complex via the adapter molecule FADD [9, 10] . T h e death receptors (Fas/CD95, T N F R l , DR3/ TRAMP, DR4/TRAIL-R1, DR5/TRAIL-R2, DR6) are a sub-group of the tumour necrosis factor/nerve growth factor receptor family that possess a 'death domain' motif within their cytoplasmic tails [ll] . It is via the death domains of these receptors that adapter molecules such as FADD and T R A D D are recruited which, in turn, recruit caspases to the complex. Upon recruitment to death receptors, caspases are brought into close proximity with other caspases and become activated via proximity-induced intermolecular processing. Other caspase/caspase adaptor molecule interactions have also been found (e.g. CARDI-AK/caspase-1 and RAIDD/caspase-2 [ 12,131) but the context(s) in which these molecules interact remains poorly defined.
Cytotoxic T-lymphocytes and natural killer cells use a serine protease (granzyme B), which also cleaves its substrates after aspartic acid residues, to activate caspases in target cells [14] . Granzyme B is released from cytotoxic T-lymphocytes/natural killer cells along with a pore forming protein, perforin, to allow entry of granzmye B into target cells. Once inside the target cell, granzyme B can initiate apoptosis by directly processing and activating several caspases [14] . In addition, granzyme B may also directly process certain caspase substrates and, thus, bypass one or more of the caspases completely.
A surprising, but well established, caspase activating mechanism that is engaged by divergent cellular stresses (e.g. cytotoxic drugs, heat shock and ionizing radiation) involves the release of mitochondrial cytochrome c into the cytoplasm in response to cellular injury [15, 16] . Elegant cellfree and biochemical studies by Wang and coworkers initially implicated cytochrome c as an essential co-factor for a caspase activating molecule, . Subsequent cloning and sequencing of Apaf-1 revealed this to be a human homologue of CED-4, a gene product that had previously been implicated, along with CED-3 (a caspase), as a key regulator of programmed cell death in C. efegans [ 161.
The mitochondrial apoptosome
Apaf-1 is a modular protein comprising three distinct domains: an N-terminal CARD that recruits procaspase-9, a CED-4-homologous region that promotes oligomerization, and a regulatory C-terminus with multiple tryptophan/ aspartic acid repeats (WD40 repeats) that appears to be the cytochrome c-responsive domain [ 17,181. Release of cytochrome c into the cytoplasm 0 200 I Biochemical Society abolishes the inhibitory action of the WD40 repeat region on Apaf-1 self-association. Oligomerization of Apaf-1, which is also facilitated by binding of dATP/ATP to the nucleotide-binding domain (CED-4-homologous region) of the latter, coincides with the recruitment of caspase-9.
In the presence of cytochrome c and dATP, Apaf-1 and caspase-9 assemble into a high molecular weight complex that has been termed 'the mitochondrial apoptosome '. T h e exact composition of the apoptosome is unclear at present, but it is likely to be composed of several Apaf-1 molecules, each of which is bound, via its CARD, to a molecule of caspase-9 [17, 19] . Apaf-1 promotes caspase-9 activation via a proximityinduced processing strategy similar to the mechanism used by death receptors to achieve caspase aggregation. However, unlike the death receptor scenario, there is evidence that caspase-9 stays associated with the apoptosome upon proteolytic maturation and that Apaf-1 acts as an allosteric regulator of caspase-9 activity (see [ 191 for a recent review).
Opening the mitochondrial poison cup board
T h e requirement for dATP/ATP for apoptosome formation suggests that mitochondria must retain function in order for apoptosis to proceed correctly. During apoptosis, the outer mitochondrial membrane (OMM) appears to allow the release of cytochrome c while simultaneously preserving mitochondrial function. So what is the nature of the pore that permits cytochrome c escape?
T h e Bcl-2 family comprises a diverse group of proteins that regulate the entry of cells into apoptosis. While some members of the Bcl-2 family promote apoptosis [the Bcl-2 homology (BH3)-only and Bax subfamilies], others are potent repressors of apoptosis (the Bcl-2-like subfamily). Both pro-and anti-apoptotic members of the Bcl-2 family have been implicated in controlling the permeability of the OMM [20] . Bcl-2 family proteins contain up to four BH domains, which comprise a-helical segments. Whereas anti-apoptotic members of the family typically possess four BH domains (BHl-BH4), pro-apoptotic members generally lack the BH4 domain [21] . T h e anti-apoptotic members, such as Bcl-2 and Bcl-XL, inhibit the release of mitochondrial cytochrome c, whereas the pro-apoptotic members, such as Bax, Bak and the BH3-only proteins, Bid, Bad and Bim, trigger its release.
T h e exact mechanism by which this occurs is still a matter of debate. However one plausible theory is that pro-apoptotic Bcl-2 family members, such as Bax and Bak, undergo conformational changes induced by BH3-only proteins [21, 22] . These conformational changes permit their insertion and/or oligomerization in the OMM, thereby forming a channel through which cytochrome c can be released (see [19] for a recent review). For example, the BH3-only family member, Bid, is cleaved by caspase-8 which triggers its translocation to mitochondria where it binds to Bak/ Bax, resulting in their oligomerization in the OMM [22] . Interestingly, a recently cloned pro-apoptotic Bcl-2 family member, Bcl-rambo, appears to induce apoptosis by facilitating mitochondrial cytochrome c release [23] . Structurally, Bcl-rambo more closely resembles the antiapoptotic Bcl-2 members, as it contains all four BH domains. However, Bcl-rambo also possesses an additional C-terminal region which appears to be responsible for its pro-apoptotic function [23] . Further elucidation of the mechanism of Bclrambo-mediated apoptosis may shed new light on the mechanism of cytochrome c release during apoptosis.
Amplification of caspase activation
Once activated within the apoptosome, caspase-9 propagates the death signal by activating downstream caspases. Cell-free systems, comprising cytoplasmic extracts prepared from viable cells, have proved valuable tools for the study of events that occur downstream of cytochrome c release. Using these systems, it has been found that a cascade of caspase activation events occurs following the activation of caspase-9 within the apoptosome [19, 24] . Caspase-3 and -7 appear to be simultaneously activated by caspase-9 [24]. T h e processing and activation of caspase-2 and -6 by caspase-3 is followed by the activation of caspase-8 and -1 0 (by caspase-6). Furthermore, in caspase-3-immunodepleted extracts a partial inhibition of caspase-9 processing is observed [24] . This suggests that a positive feedback loop between caspases-3 and -9 exists and that caspase-3 can produce a somewhat differently processed form of active caspase-9 (Figure 1) . Therefore, once caspase-9 has been activated within the apoptosome, it appears that amplification of the death signal occurs to engage a panoply of other caspases that proceed to dismantle the cell.
699

Putting the brakes on caspase activity
A number of controls that act to delay or alter the fate of the cell exist. Members of the inhibitor of apoptosis (IAP) family of proteins, such as XIAP, cIAP-1 and cIAP-2, have been found to suppress apoptosis by direct inhibition of caspases [25, 26] . Overexpression of XIAP, cIAP-1 and cIAP-2 has been shown to interfere with the activation of caspase-3, -7 and -9 downstream of mitochondria1 cytochrome c release [25, 26] . T h e structural basis for the inhibition of caspase-3, -7 and -9 by XIAP has recently been reported [26-281. Heat-shock proteins, such as Hsp70, Hsp27 and aB-crystallin, have also been implicated in the suppression of apoptosis [29-331. Hsp70 has been reported to prevent caspase activation within the apoptosome by directly associating with Apaf-1 , thereby blocking procaspase-9 recruitment [29, 30] .
The demolition phase of apoptosis
Whether all of the caspases activated in the cytochrome c-initiated cascade are essential for the cellular dismantling process remains to be fully resolved. Because it is often speculated that caspase-3, -6 and -7 are functionally redundant, their relative contributions to the demolition phase of apoptosis has recently been addressed [34] . This and other studies suggest that caspase-3 is the primary executioner caspase and that caspase-6 and -7 play relatively minor roles in this phase of apoptosis. Thus, immunodepletion of caspase-6 or -7 from cell-free extracts appeared to have minimal impact on caspase substrate cleavage, chromatin margination, DNA fragmentation and nuclear collapse [34] . This suggests that caspase-6 and -7 may play much more specialized roles in apoptosis than was initially thought.
Active caspases promote cellular demolition in several ways. By promoting cytochrome c release via proteins such as Bid (as discussed earlier), by activating other destructive enzymes such as DNases (subcontracting the work, if you will), and by directly targeting key structural and regulatory proteins within the cell for degradation [2, 5, 8] . Several important caspase-mediated substrate cleavage events that contribute to the apoptotic phenotype have now been identified. For example, caspase-activated deoxyribonuclease (CAD) is the most convincing candidate responsible for effecting internucleosomal DNA fragmentation during apoptosis [35] . CAD is normally inhibited through association with ICAD (inhibitor of CAD). However, ICAD is a caspase-3 caspase-3 substrate and its proteolytic cleavage by the latter during apoptosis permits the release of CAD, which enters the nucleus to degrade chromosomal DNA [35] . ROCK-1 (Rho-associated kinase 1) is a recently identified caspase substrate that has been proposed to drive apoptotic cell contraction and membrane blebbing [36, 37] . T h e Rho GTPases and ROCK proteins are intracellular signalling molecules that regulate the actin cytoskeleton. ROCK-1 is cleaved by caspase-3 during apoptosis to generate a truncated molecule with increased kinase activity. This increased ROCK activity and consequent membrane blebbing are required for redistribution of fragmented DNA from the nucleus into membrane blebs and apoptotic bodies [36, 37] . Caspases also appear to enhance their own activities via cleavage and inactivation of inhibitory molecules such as the apoptosis inhibitor protein, XIAP [34] . Many other caspase substrates have been identified to date; however, the significance of their cleavage within the context of apoptosis has, in many cases, still to be resolved.
SMAC: cutting the brakes
Recently, a new component of the cell death machinery, called SMAC (second mitochondrialderived activator of caspase), was reported [38] . SMAC appears to lower the threshold for entry into apoptosis by binding to IAPs, thereby removing their inhibitory activity on caspases [38] . As its name suggests, SMAC is localized in mitochondria and is released into the cytosol when cells undergo apoptosis (Figure 1) . However, the circumstances and mechanism of SMAC release from mitochondria are still poorly understood. What is known is that the N-terminal amino acids of SMAC are indispensable for its interaction with the IAPs and that active SMAC exists as a dimer [39, 40] 
Conclusion
Although our understanding of caspase activation and effector function has been greatly enhanced over the past few years, a lot of ground still remains to be covered. T h e precise role of many of the caspases that are activated during apoptosis (caspase-2, -6, -7 and -10) has yet to be determined, as has the functional significance of many of the caspase cleavage events that have been reported to date. In addition, the recent identification of SMAC, a mitochondrial-derived factor that appears to enhance caspase activation, highlights the possibility that additional caspase regulatory mechanisms have yet to be found. 
